Tarsus Pharmaceuticals Inc (TARS)

Stock price, financials, and technical signals for Tarsus Pharmaceuticals Inc (TARS).

$50.22

-2.01

(-3.85%)

As of 02/14/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

TARS Performance Snapshot


1-Week Chg

-5.16%

1-Month Chg

13.29%

3-Month Chg

7.65%

6-Month Chg

88.37%

1-Year Chg

61.90%

Year-To-Date Chg

-8.94%

Beta 1-Year

0.46

Beta 5-Year

0.98

Volatility (10-Day)

3.41%

TARS Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-02-14

$50.22

-$2.01 (-3.85%)

$52.36

$52.52

$50.01

$50.92

285.49K ($14.34M)

2025-02-13

$52.23

-$0.10 (-0.19%)

$52.75

$53.22

$51.09

$52.18

439.49K ($22.95M)

2025-02-12

$52.33

$1.11 (2.17%)

$50.65

$52.97

$50.65

$51.98

460.92K ($24.12M)

2025-02-11

$51.22

-$0.54 (-1.04%)

$51.47

$52.01

$49.86

$51.03

515.07K ($26.38M)

2025-02-10

$51.76

-$1.19 (-2.25%)

$53.33

$53.56

$50.95

$52.09

543.66K ($28.14M)

2025-02-07

$52.95

-$0.37 (-0.69%)

$53.32

$54.28

$51.34

$52.86

620.70K ($32.87M)

2025-02-06

$53.32

-$3.62 (-6.36%)

$56.57

$56.96

$52.57

$54.28

587.26K ($31.31M)

2025-02-05

$56.94

$2.44 (4.48%)

$54.89

$57.28

$54.89

$56.37

421.76K ($24.01M)

2025-02-04

$54.50

$0.36 (0.66%)

$54.71

$55.98

$54.21

$54.90

310.38K ($16.92M)

2025-02-03

$54.14

$0.38 (0.71%)

$52.47

$56.21

$52.08

$54.14

399.76K ($21.64M)

TARS Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $176.21M

    -22.26%

  • Total assets

    $376.30M

    40.24%

  • Total liabilities

    $138.82M

    153.93%

  • Total investments

    $143.74M

    603.82%

  • Shareholders' equity

    $237.48M

    11.15%

  • Book value per share

    $6.19

    -11.32%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $48.12M

    2471.78%

  • Net income

    -$23.42M

    40.18%

  • Operating expense

    $70.04M

    65.07%

  • Gross profit

    $44.88M

    2903.75%

  • EBITDA

    -$20.52M

    45.88%

  • Earnings per share

    -$0.61

    52.34%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    -$4.88M

    -104.07%

  • Cash from operations

    -$8.65M

    73.26%

  • Cash from investing

    $3.13M

    -93.40%

  • Cash from financing

    $639.00K

    -99.39%

  • Free cash flow

    -$8.93M

    75.68%

  • Free cash flow per share

    -$0.23

    80.58%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $1.25B

    115.87%

  • Enterprise value

    $1.14B

    129.52%

  • Shares outstanding

    38.04M

    16.63%

  • Profit margin

    -48.70%

    97.67%

  • Gross margin

    93.30%

    16.77%

  • EBITDA margin

    -42.70%

    97.89%


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    5.42

    -51.38%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.